(1) Kaplon H., Reichert J. M. Antibodies to watch in 2019. MAbs 2019, 11 (2), 219–238.
(2) Surjit S., Nitish K. T., Pradeep D., Jaykaran C., Rimplejeet K., Preeti. S., Vinay. K. C. Monoclonal antibodies. A review. Indian J. Med. Sci. 2001, 55 (12), 651–654.
(3) Kaltashov, I. A., Bobst C. E., Abzalimov R. R., Wang G., Baykal B., Wang S., Wang S. Advance and challenges in analytical characterization of biotechnologt products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics. Biotechnol. Adv. 2013, 30 (1), 210–222.
(4) Kerwin B. A., Remmele R. L. Protect from light: Photodegradation and protein biologics. J. Pharm. Sci. 2007, 96 (6), 1468–1479.
(5) Pattison D. I., Rahmanto A. S., Davies M. J. Photo-oxidation of proteins. Photochem. Photobiol. Sci. 2012, 11 (1), 38–53.
(6) Mason B. D., Schöneich C., Kerwin B. A. Effect of pH and light on aggregation and conformation of an IgG1 mAb. Mol. Pharm. 2012, 9 (4), 774–790.
(7) Bommana R., Chai Q., Schöneich C., Weiss W. F., Majumdar R. Understanding the increased aggregation propensity of a light-exposed IgG1 monoclonal antibody using hydrogen exchange mass spectrometry, biophysical characterization, and structural analysis. J. Pharm. Sci. 2018, 107 (6), 1498–1511.
(8) Tomita M., Irie M., Ukita T. Sensitized photooxidation of histidine and its derivatives. products and mechanism of the reaction. Biochemistry 1969, 8 (12), 5149–5160.
(9) Tomita M., Irie M., Ukita T. Sensitized photooxidation of N-benzoyl histidine. Tetrahedron Lett. 1968, 9 (47), 4933–4936.
(10) Bane, J., Mozziconacci, O., Yi, L., Wang, Y. J., Sreedhara, A., Schöneich, C. Photo- oxidation of IgG1 and model peptides: Detection and analysis of triply oxidized His and Trp side chain cleavage products. Pharm. Res. 2017, 34 (1), 229–242.
(11) Amano M., Kobayashi N., Yabuta M., Uchiyama S., Fukui K. Detection of histidine oxidation in a monoclonal immunoglobulin gamma (IgG) 1 antibody. Anal. Chem. 2014, 86 (15), 7536–7543.
(12) Chen J., Bergevin J., Kiss R., Walker G., Battistoni T., Lufburrow P., Lam H., Vinther A. Case study: A novel bacterial contamination in cell culture production - Leptospira licerasiae PDA J. Pharm. Sci. Technol. 2012, 66 (6), 580–591.
(13) Drexler H. G., Uphoff C. C. Mycoplasma contamination of cell cultures: Incidence, sources, effects, detection, elimination, prevention. Cytotechnology 2002, 39 (2), 75–90.
(14) Aranha H. Virus safety of absence of evidence is not evidence of absence. Contract Pharma 2011, November/December.
(15) Moody M., Alves W., Varghese J., Khan F. Mouse minute virus (MMV) contamination A case study: Detection, root cause determination, and corrective actions. PDA J. Pharm. Sci. Technol. 2011, 65 (6), 580–588.
(16) Goetschalckx S., Fabre V., Wynants M., Bertaux L., Plavsic M., Boussif O., Laenen L. A holistic biosafety risk mitigation approach. 2014, Amer Pharm Rev 17(4), 48–56.
(17) Reed, N. G. The History of ultraviolet germicidal irradiation for air disinfection. Public Health Rep. 2010, 125 (1), 15–27.
(18) Tseng C. C., Li C. S. Inactivation of viruses on surfaces by ultraviolet germicidal irradiation. J. Occup. Environ. Hyg. 2007, 4 (6), 400–405.
(19) Vaidya V., Dhere R., Agnihotri S., Muley R., Patil S., Pawar A. Ultraviolet-C irradiation for inactivation of viruses in foetal bovine serum. Vaccine 2018, 36 (29), 4215–4221.
(20) Lorenz C. M., Wolk B. M., Quan C. P., Alcala E. W., Eng M., McDonald D. J., Matthews T. C. The effect of low intensity ultraviolet-C light on monoclonal antibodies. Biotechnol. Prog. 2009, 25 (2), 476–482.
(21) Chan H. L., Gaffney P. R., Waterfield M. D., Anderle H., Matthiessen H.P., Schwarz, H. P., Turecek P. L., Timms J. F. Proteomic analysis of uvc irradiation-induced damage of plasma proteins: Serum amyloid P component as a major target of photolysis. FEBS Lett. 2006, 580 (13), 3229–3236.
(22) Roopenian D. C., Akilesh S. FcRn: The neonatal fc receptor comes of age. Nat. Rev. Immunol. 2007, 7 (9), 715–725.
(23) Wang X., Mathieu M., Brezski R. J. IgG Fc engineering to modulate antibody effector functions. Protein Cell 2018, 9 (1), 63–73.
(24) Moore G. L., Chen H., Karki S., Lazar G. A. Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions. 2010, 2 (2), 181– 189.
(25) Taylor P., Mimoto F., Igawa T., Kuramochi T., Katada H., Kadono S., Kamikawa T. Novel asymmetrically engineered antibody Fc variant with superior FcγR binding affinity and specificity compared with afucosylated Fc variant. MAbs 2015, 5 (2), 37–41.
(26) Burmeister W. P., Huber A. H., Bjorkman P. J. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 1994, 372 (24), 379–383.
(27) Shimizu A., Honzawa M., Ito S., Miyazaki T., Matsumoto H., Nakamura H., Michaelsen T. E., Arata, Y. 1H NMR studies of the Fc region of human IgG1 and IgG3 immunoglobulins: Assignment of histidine resonances in the CH3 domain and identification of IgG3 protein carrying G3m(st) allotypes. Mol. Immunol. 1983, 20 (2), 141–148.
(28) Shields R. L., Namenuk A. K., Hong K., Meng Y. G., Rae J., Brigg, J., Xie D., Lai J., Stadlen A., Li B. High resolution mapping of the binding site on human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and design of IgG1 variants with improved binding to the FcγR. J. Biol. Chem. 2001, 276 (9), 6591–6604.
(29) Zhang G., Annan R. S., Carr S. A., Neubert T. A. Overview of peptide and protein analysis by mass spectrometry. Curr. Protoc. Mol. Biol. 2014, 10.21.1-10.21.30.
(30) Yates J. R., Ruse C. I., Nakorchevsky A. Proteomics by mass spectrometry: approaches, advances, and applications. Annu. Rev. Biomed. Eng. 2009, 11, 49–79.
(31) Zhang H., Cui W., Gross M. L. Mass spectrometry for the biophysical characterization of therapeutic monoclonal antibodies. FEBS Lett. 2014, 588 (2), 308–317.
(32) Amano M., Hasegawa J., Kobayashi N., Kishi N., Nakazawa T., Uchiyama S., Fukui K. Specific racemization of heavy-chain cysteine-220 in the hinge region of immunoglobulin gamma 1 as a possible cause of degradation during storage. Anal. Chem. 2011, 83 (10), 3857–3864.
(33) Kuo T. T., Aveson V. G. Neonatal Fc receptor and igg-based therapeutics. MAbs 2011, 3 (5), 422–430.
(34) Amano M., Fukui K., Uchiyama S. Suppression of methionine oxidation of a pharmaceutical antibody stored in a polymer-based syringe. J. Pharm. Sci. 2016, 105 (2), 623–629.
(35) Yan S. F., Ramasamy R., Schmidt A. M. Mechanisms of disease: Advanced glycation endproducts and their receptor in inflammation and diabetes complications. Nat. Clin. Pract. Endocrinol. Metab. 2008, 4 (5), 285–293.
(36) Heidebrecht T., Christodoulou E., Chalmers M. J., Jan S., Ter Riet B., Grover R. K., Joosten R. P., Littler D., Luenen v. H., Griffin P. R., Wentworth Jr P., Borst P., Perrakis A. The structural basis for recognition of base J containing DNA by a novel DNA binding domain in JBP1. Nucleic Acids Res. 2011, 39 (13), 5715–5728.
(37) Harris R. J., Kabakoff B., Macchi F. D., Shen F. J., Kwong M., Andya J. D., Shire S. J., Bjork N., Totpal K., Chen, A. B. Identification of multiple sources of charge heterogeneity in a recombinant antibody. J. Chromatogr. B Biomed. Sci. Appl. 2001, 752 (2), 233–245.
(38) DeGraan-Weber N., Zhang J., Reilly J. P. Distinguishing aspartic and isoaspartic acids in peptides by several mass spectrometric fragmentation methods. J. Am. Soc. Mass Spectrom. 2016, 27 (12), 2041–2053.
(39) Agon V. V., Bubb W. A., Wright A., Hawkins C. L., Davies M. J. Sensitizer-mediated photooxidation of histidine residues: evidence for the formation of reactive side-chain peroxides. Free Radic. Biol. Med. 2006, 40 (4), 698–710.
(40) Castaño C., Oliveros E., Thomas A. H., Lorente C. Histidine oxidation photosensitized by pterin: pH dependent mechanism. J. Photochem. Photobiol. B Biol. 2015, 153, 483–489.
(41) Davies M. J. Singlet oxygen-mediated damage to proteins and its consequences. Biochem. Biophys. Res. Commun. 2003, 305 (3), 761–770.
(42) Foote C. S. Definition of type I and type II photosensitized oxidation. Photochem. Photobiol. 1991, 54 (5), 659.
(43) Yang H., Zubarev R. A. Mass spectrometric analysis of asparagine deamidation and aspartate isomerization in polypeptides. Electrophoresis 2010, 31 (11), 1764–1772.
(44) Spicer V., Yamchuk, A., Cortens, J., Sousa S., Ens W., Standing K. G., Wilkins J. A., Krokhin O. V. Sequence-specific retention calculator. a family of peptide retention time prediction algorithms in reversed-phase HPLC: Applicability to various chromatographic conditions and columns. Anal. Chem. 2007, 79 (22), 8762–8768.
(45) Vu, H.; Spicer, V.; Gotfrid, A.; Krokhin, O. V. A model for predicting slopes S in the basic equation for the linear-solvent-strength theory of peptide separation by reversed-phase high-performance liquid chromatography. J. Chromatogr. A 2010, 1217 (4), 489–497.
(46) Méndez-Hurtado J., Lõpez R., Suárez D., Menéndez M. I. Theoretical study of the oxidation of histidine by singlet oxygen. Chem. - A Eur. J. 2012, 18 (27), 8437–8447.
(47) Murahashi S., Yuki H., Kosai K., Doura F. Methylene-hydantoin and related compounds. I. On the reaction of pyruvic acid and urea: The synthesis of 5-methylene-hydantoin. Bull. Chem. Soc. Jpn. 1966, 39 (7), 1559–1562.
(48) Vacher M., Fdez Galván I., Ding B. W., Schramm S., Berraud-Pache R., Naumov P., Ferré N., Liu Y. J., Navizet I., Roca-Sanjuán D., Baader W. J., Lindh R. Chemi- and bioluminescence of cyclic peroxides. Chem. Rev. 2018, 118 (15), 6927–6974.
(49) Mazur, S., Foote, C. S. Chemistry of singlet oxygen. IX. Stable dioxetane from photooxygenation of tetramethoxy ethylene. J. Am. Chem. Soc. 1970, 92 (10), 3225-3226.
(50) Ohloff, G. Singlet oxygen: a reagent in organic synthesis, Pure and Applied Chemistry, 1975, 43 (3-4), 481-502
(51) Nishiwaki N., Tohda Y., Ariga M. Facile synthesis of functionalized nitroenamines. III. Aminolysis of 1-methyl-5-nitropyrimidin-2(1H)-one. Bull. Chem. Soc. Jpn. 1996, 69 (7), 1997-2002
(52) McFadden P. N., Clarke S. Methylation at D-aspartyl residues in erythrocytes: Possible step in the repair of aged membrane proteins. Proc. Natl. Acad. Sci. U. S. A. 1982, 79 (8), 2460–2464.
(53) Remucal C. K., McNeill K. Photosensitized amino acid degradation in the presence of riboflavin and its derivatives. Environ. Sci. Technol. 2011, 45 (12), 5230–5237.
(54) Miyagi M., Nakazawa T. Determination of pKa values of individual histidine residues in proteins using mass spectrometry. Anal. Chem. 2008, 80 (17), 6481–6487.
(55) Hayashi N., Kuyama H., Nakajima C., Kawahara K., Miyagi M., Nishimura O., Matsuo H., Nakazawa T. Imidazole C-2 hydrogen/deuterium exchange reaction at histidine for probing protein structure and function with matrix-assisted laser desorption ionization mass spectrometry. Biochemistry 2014, 53 (11), 1818–1820f.
(56) Serrano-Andrés, L., Fülscher, M. P., Karlström, G. Solvent effects on electronic spectra studied by multiconfigurational perturbation theory. Int. J. Quantum Chem. 1997, 65 (2), 167–181.
(57) Serrano-Andrés, L., Fülscher, M. P.; Roos, B. O., Merchán, M. Theoretical study of the electronic spectrum of imidazole. J. Phys. Chem. 1996, 100 (16), 6484–6491.
(58) Barbatti, M., Lischka, H., Salzmann, S., Marian, C. M. UV excitation and radiationless deactivation of imidazole. J. Chem. Phys. 2009, 130 (3).
(59) Sasaki Y., Zukawa T., Kurosawa T., Nagao N., Kamiko N. Development of ultravioletlight-emitting light source and water treatment technology. Panasonic Technical Journal 2017, 63 (1), 101–106.